OPHTACARE
The computed 12-month bankruptcy probability of OPHTACARE is 0.2% (very low). The 2024 annual accounts show equity of €115k and a net result of €49k. Equity is growing by ~55.8% per year across the filed fiscal years. The company has been active since 1998 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €115k |
| Net result | €49k |
| Staff (FTE) | 6.1 |
| Active | 28 yrs |
Exceptional profile — strong across almost every axis.
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil–Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Fiscal year | 2024 |
|---|---|
| Revenue | — |
| EBITDA | €149k |
| Net profit | €49k |
| Cash flow | €115k |
| Staff costs | €145k |
| Income taxes | €27k |
| Dividends | — |
| Total assets | €215k |
| Equity | €115k |
| Debt | €100k |
| of which ≤ 1y | €34k |
| of which > 1y | €66k |
| Working capital | €38k |
| Employees (FTE) | 6.1 |
| 2024 | |
|---|---|
| Current ratio | 2.13 |
| Quick ratio | 2.13 |
| Working capital ratio | 17.7% |
| Solvency | 53.4% |
| Debt / equity | 0.87 |
| Long-term debt ratio | 0.58 |
| Interest coverage | 21.74 |
| Gross margin | — |
| Net margin | — |
| ROA | 22.8% |
| ROE | 42.7% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €215k |
| Fixed assets | 21/28 | €143k |
| Tangible fixed assets | 22/27 | €139k |
| Financial fixed assets | 28 | €4k |
| Current assets | 29/58 | €72k |
| Amounts receivable within one year | 40/41 | €10k |
| Cash & bank | 54/58 | €25k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €215k |
| Equity | 10/15 | €115k |
| Contributions / capital | 10/11 | €19k |
| Reserves | 13 | €169k |
| Accumulated profits (losses) | 14 | €-73k |
| Amounts payable | 17/49 | €100k |
| Amounts payable after one year | 17 | €66k |
| Amounts payable within one year | 42/48 | €34k |
| Trade debts payable within one year | 44 | €7k |
| Income statement | ||
| Gross operating margin | 9900 | €300k |
| Operating result | 9901 | €83k |
| Financial income | 75 | €28 |
| Financial charges | 65 | €7k |
| Result before taxes | 9903 | €76k |
| Income taxes | 67/77 | €27k |
| Net result for the period | 9904 | €49k |
| Result to be appropriated | 9905 | €49k |
| NACE primary | Human health(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 23-06-1998 |
| Status | Active |
| Postal code | 1050 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21013B0377/00E000 | Brussels | 3.7 ha | 1 · 267 m² | 20.4 m · 2 fl. |
| 21018A0029/00S000 | Brussels | 1,578 m² | 1 · 421 m² | 16.5 m · 4 fl. |
| 21392B0038/00H008 | Brussels | 1,113 m² | 1 · 836 m² | 20.3 m · 5 fl. |
| 21807G0111/00G000 | Brussels | 396 m² | 1 · 273 m² | 36.8 m · 7 fl. |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
05-01-2024 WEISS Mohamad Azzam reappointed as director
- WEISS Mohamad Azzam — Bestuurder
Technical details
{
"events": [
{
"kind": "decharge_pending",
"role": null,
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cidera \u00E0 la prochaine assembl\u00E9e g\u00E9n\u00E9rale annuelle sur la d\u00E9charge au g\u00E9rant d\u00E9missionnaire pour l\u2019ex\u00E9cution de son mandat.",
"decharge_status": "pending_next_agm",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_renew",
"role": "administrateur",
"person": {
"rrn": null,
"name": "WEISS Mohamad Azzam",
"address": "1970 Wezembeek-Oppem, Rue de la Petite Montagne 3",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": null,
"statutory": "niet_statutair",
"compensated": false,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de mettre fin \u00E0 la fonction du g\u00E9rant actuel, mentionn\u00E9 ci-apr\u00E8s, et proc\u00E8de imm\u00E9diatement au renouvellement de sa nomination comme administrateur non statutaire pour une dur\u00E9e illimit\u00E9e : - Monsieur WEISS Mohamad Azzam, domicili\u00E9 \u00E0 1970 Wezembeek-Oppem, Rue de la Petite ",
"decharge_status": null,
"mandate_duration": {
"kind": "indefinite",
"value": null
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Laurent VANNESTE",
"firm_city": null,
"firm_name": null,
"office_city": "Ixelles",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-01-05",
"filing_date": "2024-01-03",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-12-27",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0463.558.248",
"name_full": "OPHTACARE",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Laurent VANNESTE",
"org_rep_person_name": null,
"person_role_at_subject": "notaire"
},
"co_filed_documents": [
"une exp\u00E9dition de l\u0027acte"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | OPHTACARE |